Pharmacotherapy for Liver Cirrhosis and Its Complications
Springer Verlag, Singapore
978-981-19-2614-3 (ISBN)
Xingshun Qi is an Associate Professor at the Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.Yongping Yang is a Professor at Department of Liver Disease, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Anti-HBV drugs in liver cirrhosis.- Anti-HCV drugs in liver cirrhosis.- Anticoagulants in liver cirrhosis.- Antibiotics in liver cirrhosis.- Silymarin in liver cirrhosis.- Ursodeoxycholic acid in liver cirrhosis.- Emricasan in liver cirrhosis.- Non-selective beta blockers in liver cirrhosis.- Somatostatin and octreotide in liver cirrhosis.- Terlipressin in liver cirrhosis.- Diuretics in liver cirrhosis.- Statins in liver cirrhosis.- L-Ornithine L-Aspartate in liver cirrhosis.- Lactulose in liver cirrhosis.
Erscheinungsdatum | 29.07.2022 |
---|---|
Zusatzinfo | 16 Illustrations, color; 4 Illustrations, black and white; XII, 240 p. 20 illus., 16 illus. in color. |
Verlagsort | Singapore |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
ISBN-10 | 981-19-2614-X / 981192614X |
ISBN-13 | 978-981-19-2614-3 / 9789811926143 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich